Abiopharma

🔍 Allison Schwartz (Director)

Company: BIO-RAD LABORATORIES, INC. (BIO BIO.B)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Acquired 147 shares of Bio-Rad A Common Stock (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,452.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 55 shares of Bio-Rad A Common Stock at $297.88 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,397.00 | transaction_form_type: 4
• Sold 31 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 42 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 42.00 | transaction_form_type: 4 | Footnotes: F2, F4, F4
• Sold 74 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 150.00 | transaction_form_type: 4 | Footnotes: F2, F5, F5

Footnotes:

• F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
• F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
• F3: On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
• F4: On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
• F5: On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.